381 related articles for article (PubMed ID: 8462769)
21. In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes.
Cam MC; Cros GH; Serrano JJ; Lazaro R; McNeill JH
Diabetes Res Clin Pract; 1993 May; 20(2):111-21. PubMed ID: 8375263
[TBL] [Abstract][Full Text] [Related]
22. Effects of vanadyl sulphate on glucose homeostasis in severe diabetes induced by streptozotocin in rats.
Dehghani GA; Ahmadi S; Omrani GR
Indian J Med Res; 1997 Nov; 106():481-5. PubMed ID: 9415745
[TBL] [Abstract][Full Text] [Related]
23. Effect of Vanadyl Rosiglitazone, a New Insulin-Mimetic Vanadium Complexes, on Glucose Homeostasis of Diabetic Mice.
Jiang P; Dong Z; Ma B; Ni Z; Duan H; Li X; Wang B; Ma X; Wei Q; Ji X; Li M
Appl Biochem Biotechnol; 2016 Nov; 180(5):841-851. PubMed ID: 27240663
[TBL] [Abstract][Full Text] [Related]
24. Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment.
Ramanadham S; Brownsey RW; Cros GH; Mongold JJ; McNeill JH
Metabolism; 1989 Oct; 38(10):1022-8. PubMed ID: 2677609
[TBL] [Abstract][Full Text] [Related]
25. Improvement of diabetic states in streptozotocin-induced type 1 diabetic rats by vanadyl sulfate in enteric-coated capsules.
Fugono J; Yasui H; Sakurai H
J Pharm Pharmacol; 2005 May; 57(5):665-9. PubMed ID: 15901357
[TBL] [Abstract][Full Text] [Related]
26. Toxicity studies on one-year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate.
Dai S; Thompson KH; Vera E; McNeill JH
Pharmacol Toxicol; 1994 Nov; 75(5):265-73. PubMed ID: 7870697
[TBL] [Abstract][Full Text] [Related]
27. Myoinositol ameliorates high-fat diet and streptozotocin-induced diabetes in rats through promoting insulin receptor signaling.
Antony PJ; Gandhi GR; Stalin A; Balakrishna K; Toppo E; Sivasankaran K; Ignacimuthu S; Al-Dhabi NA
Biomed Pharmacother; 2017 Apr; 88():1098-1113. PubMed ID: 28192884
[TBL] [Abstract][Full Text] [Related]
28. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
Yao J; Battell ML; McNeill JH
Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
[TBL] [Abstract][Full Text] [Related]
29. Conformation changes in brain calcineurin in diabetic rats with or without treatment with vanadyl sulfate.
Li H; Wei Q
IUBMB Life; 2001 Jun; 51(6):373-6. PubMed ID: 11758805
[TBL] [Abstract][Full Text] [Related]
30. Mechanism on insulin-like action of vanadyl sulfate: studies on interaction between rat adipocytes and vanadium compounds.
Nakai M; Watanabe H; Fujiwara C; Kakegawa H; Satoh T; Takada J; Matsushita R; Sakurai H
Biol Pharm Bull; 1995 May; 18(5):719-25. PubMed ID: 7492989
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
Bolkent S; Bolkent S; Yanardag R; Tunali S
Diabetes Res Clin Pract; 2005 Nov; 70(2):103-9. PubMed ID: 16188572
[TBL] [Abstract][Full Text] [Related]
32. Vanadium and diabetes.
Poucheret P; Verma S; Grynpas MD; McNeill JH
Mol Cell Biochem; 1998 Nov; 188(1-2):73-80. PubMed ID: 9823013
[TBL] [Abstract][Full Text] [Related]
33. Studies of vanadyl sulfate as a glucose-lowering agent in STZ-diabetic rats.
Thompson KH; Leichter J; McNeill JH
Biochem Biophys Res Commun; 1993 Dec; 197(3):1549-55. PubMed ID: 8280174
[TBL] [Abstract][Full Text] [Related]
34. Enhanced in vivo sensitivity of vanadyl-treated diabetic rats to insulin.
Ramanadham S; Cros GH; Mongold JJ; Serrano JJ; McNeill JH
Can J Physiol Pharmacol; 1990 Apr; 68(4):486-91. PubMed ID: 2183918
[TBL] [Abstract][Full Text] [Related]
35. Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects.
Domingo JL; Gómez M; Llobet JM; Corbella J; Keen CL
Pharmacol Toxicol; 1991 Apr; 68(4):249-53. PubMed ID: 1866388
[TBL] [Abstract][Full Text] [Related]
36. Oral vanadium administration to streptozotocin-diabetic rats has marked negative side-effects which are independent of the form of vanadium used.
Domingo JL; Gomez M; Llobet JM; Corbella J; Keen CL
Toxicology; 1991 Mar; 66(3):279-87. PubMed ID: 1826377
[TBL] [Abstract][Full Text] [Related]
37. [Comparative characteristics of vanadium-containing compounds, possessing insulin-like effects].
Golubev MA; Gorodetskiĭ VK; Anis'kina AP; Tochilkin AI; Beliaeva NF
Vopr Med Khim; 2000; 46(2):155-61. PubMed ID: 10885036
[TBL] [Abstract][Full Text] [Related]
38. Partial preservation of pancreatic beta-cells by vanadium: evidence for long-term amelioration of diabetes.
Cam MC; Li WM; McNeill JH
Metabolism; 1997 Jul; 46(7):769-78. PubMed ID: 9225830
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of various vanadium salts on glucose homeostasis in streptozotocin-diabetic rats.
Becker DJ; Ongemba LN; Henquin JC
Eur J Pharmacol; 1994 Aug; 260(2-3):169-75. PubMed ID: 7988641
[TBL] [Abstract][Full Text] [Related]
40. Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV).
Yuen VG; Orvig C; Thompson KH; McNeill JH
Can J Physiol Pharmacol; 1993; 71(3-4):270-6. PubMed ID: 8402391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
